U.S. markets open in 2 hours 56 minutes

Cleveland BioLabs, Inc. (CBLI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.03+0.70 (+16.17%)
At close: 4:00PM EST

4.41 -0.62 (-12.33%)
Before hours: 6:04AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.33
Open4.35
Bid0.00 x 900
Ask5.47 x 1200
Day's Range4.33 - 5.88
52 Week Range1.27 - 5.88
Volume1,131,446
Avg. Volume344,995
Market Cap65.472M
Beta (5Y Monthly)0.64
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the Firm
    GlobeNewswire

    ALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the Firm

    NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CounterPath Corporation (NASDAQ: CPAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Alianza, Inc. for $3.49 per share. If you are a CounterPath shareholder, click here to learn more about your rights and options.Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cytocom, Inc. Under the merger, Cleveland BioLabs stockholders are expected to own approximately 39% of the combined company. If you are a Cleveland BioLabs shareholder, click here to learn more about your rights and options.QEP Resources, Inc. (NYSE: QEP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Diamondback Energy, Inc. for 0.05 shares of Diamondback common stock for each share of QEP common stock. If you are a QEP shareholder, click here to learn more about your rights and options.Seneca Biopharma, Inc. (NASDAQ: SNCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Leading BioSciences, Inc. If you are a Seneca shareholder, click here to learn more about your rights and options.Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.Attorney Advertising. Prior results do not guarantee a similar outcome.Contact Information: Halper Sadeh LLP Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 sadeh@halpersadeh.com zhalper@halpersadeh.com

  • ACCESSWIRE

    Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV

    NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.